Work

A phase II trial of cetuximab as therapy for recurrent non-small cell lung cancer (NSCLC): Final results

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.7036

Authors: R. Lilenbaum, P. Bonomi, R. Ansari, T. Lynch, R. Govindan, P. Janne, N. Hanna

Institutions: Dana-Farber Cancer Institute, Northern Indiana Cancer Research Consortium, Rush University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2589302543

Cites:

Cited by: 40

Related to: 10